Your browser doesn't support javascript.
loading
Cancer cell-derived CD69 induced under lipid and oxygen starvation promotes ovarian cancer progression through fibronectin.
Koizume, Shiro; Kanayama, Tomohiko; Kimura, Yayoi; Hirano, Hisashi; Takahashi, Tomoko; Ota, Yukihide; Miyazaki, Kaoru; Yoshihara, Mitsuyo; Nakamura, Yoshiyasu; Yokose, Tomoyuki; Kato, Hisamori; Takenaka, Katsuya; Sato, Shinya; Tadokoro, Hiroko; Miyagi, Etsuko; Miyagi, Yohei.
Afiliação
  • Koizume S; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Kanayama T; Department of Pathology, Kanagawa Cancer Center Hospital, Yokohama, Japan.
  • Kimura Y; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Hirano H; Advancer Medical Research Center, Yokohama City University, Yokohama, Japan.
  • Takahashi T; Advancer Medical Research Center, Yokohama City University, Yokohama, Japan.
  • Ota Y; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Miyazaki K; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Yoshihara M; Department of Obstetrics, Gynecology and Molecular Reproductive Science, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Nakamura Y; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Yokose T; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Kato H; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Takenaka K; Department of Pathology, Kanagawa Cancer Center Hospital, Yokohama, Japan.
  • Sato S; Department of Gynecology, Kanagawa Cancer Center Hospital, Yokohama, Japan.
  • Tadokoro H; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Miyagi E; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan.
  • Miyagi Y; Department of Pathology, Kanagawa Cancer Center Hospital, Yokohama, Japan.
Cancer Sci ; 114(6): 2485-2498, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36854451
ABSTRACT
Cancer tissues generally have molecular oxygen and serum component deficiencies because of poor vascularization. Recently, we revealed that ICAM1 is strongly activated through lipophagy in ovarian clear cell carcinoma (CCC) cells in response to starvation of long-chain fatty acids and oxygen and confers resistance to apoptosis caused by these harsh conditions. CD69 is a glycoprotein that is synthesized in immune cells and is associated with their activation through cellular signaling pathways. However, the expression and function of CD69 in nonhematological cells is unclear. Here, we report that CD69 is induced in CCC cells as in ICAM1. Mass spectrometry analysis of phosphorylated peptides followed by pathway analysis revealed that CD69 augments CCC cell binding to fibronectin (FN) in association with the phosphorylation of multiple cellular signaling molecules including the focal adhesion pathway. Furthermore, CD69 synthesized in CCC cells could facilitate cell survival because the CD69-FN axis can induce epithelial-mesenchymal transition. Experiments with surgically removed tumor samples revealed that CD69 is predominantly expressed in CCC tumor cells compared with other histological subtypes of epithelial ovarian cancer. Overall, our data suggest that cancer cell-derived CD69 can contribute to CCC progression through FN.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Fibronectinas Limite: Female / Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Fibronectinas Limite: Female / Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão